Skip to main content
OpenTrials

Clinical trial condition

Autoimmune Diseases of the Nervous System

Explore clinical trials studying Autoimmune Diseases of the Nervous System. Study availability and eligibility vary by location and protocol.

3,224 public trials 544 recruiting studies
Refine in advanced search Browse all conditions

Autoimmune Diseases of the Nervous System trial results

Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD)

NCT05063162

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +2 more
Locations
  • Mog001 50297 Scottsdale, Arizona, United States
  • Mog001 50450 Palo Alto, California, United States
  • Mog001 50101 Aurora, Colorado, United States
  • Mog001 50553 Washington D.C., District of Columbia, United States
View all 55 locations
View Trial Details
Active, Not Recruiting

Validation and Standardization of Paramagnetic Rim Lesion (PRL) Identification in Multiple Sclerosis Across MAGNIMS Centers

NCT07705581

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Medical University Graz Graz, Austria
  • Medical University of Vienna Vienna, Austria
  • Charles University and General University Hospital Prague, Czechia
  • Danish Research Centre for Magnetic Resonance Copenhagen, Denmark
View all 15 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)

NCT05123703

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • UC San Diego La Jolla, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins Medicine Baltimore, Maryland, United States
View all 71 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple Sclerosis

NCT07008378

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • UCI Sue & Bill Gross Stem Cell Research Center Irvine, California, United States
  • UCSD Altman Clinical and Translational Research Institute La Jolla, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Rutgers University- Robert Wood Johnson Medical School New Brunswick, New Jersey, United States
View Trial Details
Active, Not Recruiting

OFSEP Very High Definition Cohort

NCT05622643

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • CHU de Lyon Lyon, France
  • CHU de Nancy Nancy, France
  • CHU de Nîmes Nîmes, France
  • CHU de Rennes Rennes, France
View Trial Details
Active, Not Recruiting

A Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of RPH-035 and Ocrevus® in Patients With Relapsing-remitting or Secondary Progressive Multiple Sclerosis With Exacerbations

NCT07597668

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • State Autonomous Healthcare Institution Regional Clinical Hospital No. 3 Chelyabinsk, Russia
  • Kazan State Medical Academy, branch of the Federal State Budgetary Educational Institution of Additional Professional Education Russian Medical Academy of Continuing Professional Education Kazan', Russia
  • State Autonomous Healthcare Institution "Interregional Clinical and Diagnostic Center" Kazan', Russia
  • Kirov Regional State Clinical Budgetary Healthcare Institution "Center for Cardiology and Neurology" Kirov, Russia
View all 23 locations
View Trial Details
Active, Not Recruiting

OFSEP High Definition Cohort

NCT03603457

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • CHU de Besançon Besançon, France
  • CHU de Bordeaux Bordeaux, France
  • CHU de Caen Caen, France
  • CHU de Clermont-Ferrand Clermont-Ferrand, France
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

NCT05070858

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • HonorHealth Neurology 2018 Scottsdale, Arizona, United States
  • University of California Irvine Irvine, California, United States
  • University of Southern California Los Angeles, California, United States
  • Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
View all 116 locations
View Trial Details

Related conditions